Agilent Technologies Inc
DUS:AG8
Relative Value
The Relative Value of one
AG8
stock under the Base Case scenario is
147.61
EUR.
Compared to the current market price of 98.22 EUR,
Agilent Technologies Inc
is
Undervalued by 33%.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Multiples Across Competitors
AG8 Competitors Multiples
Agilent Technologies Inc Competitors
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| US |
|
Agilent Technologies Inc
DUS:AG8
|
31.9B EUR | 4.5 | 24.7 | 18.2 | 21.5 | |
| US |
P
|
PerkinElmer Inc
LSE:0KHE
|
979.9B USD | 343.1 | 4 062.5 | 1 164.1 | 2 241.6 | |
| US |
|
Thermo Fisher Scientific Inc
NYSE:TMO
|
177.8B USD | 4 | 26.5 | 18.5 | 24.9 | |
| US |
|
Danaher Corp
NYSE:DHR
|
138B USD | 5.6 | 38.2 | 19.4 | 28.2 | |
| KR |
|
Samsung Biologics Co Ltd
KRX:207940
|
82.3T KRW | 18.1 | 46.1 | 30.1 | 39.4 | |
| CH |
|
Lonza Group AG
SIX:LONN
|
33.5B CHF | 5.1 | 35.2 | 26.2 | 26.2 | |
| CN |
|
WuXi AppTec Co Ltd
SSE:603259
|
264.5B CNY | 6 | 17.6 | 17.7 | 17.7 | |
| US |
|
Waters Corp
NYSE:WAT
|
29.1B USD | 9.2 | 45.3 | 29.3 | 36.8 | |
| US |
|
IQVIA Holdings Inc
NYSE:IQV
|
28.6B USD | 1.8 | 21.1 | 11.8 | 17.7 | |
| US |
|
Mettler-Toledo International Inc
NYSE:MTD
|
24.6B USD | 6.1 | 28.3 | 21.1 | 23.4 | |
| FR |
|
Sartorius Stedim Biotech SA
PAR:DIM
|
17B EUR | 5.8 | 64.3 | 21.7 | 34.6 |